Pharmazz Revenue and Competitors

IL, IL HONDURAS

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharmazz's estimated annual revenue is currently $8.8M per year.(i)
  • Pharmazz's estimated revenue per employee is $201,000

Employee Data

  • Pharmazz has 44 Employees.(i)
  • Pharmazz grew their employee count by -4% last year.

Pharmazz's People

NameTitleEmail/Phone
1
Pharmacovigilance officer inchargeReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Assistant Medical DirectorReveal Email/Phone
4
Project ManagerReveal Email/Phone
5
Scientific Affairs ManagerReveal Email/Phone
6
Manager (Market Research and Pharmacoeconomics)Reveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Sr.Manager Leading Analytical Research Dept.Reveal Email/Phone
9
Deputy Manager - HR & OperationsReveal Email/Phone
10
Account ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.9M7930%N/AN/A
#2
$91.5M4557%N/AN/A
#3
$26.1M13025%$35MN/A
#4
$15.3M76-4%N/AN/A
#5
$6.6M33-25%N/AN/A
#6
$5.6M28-7%N/AN/A
#7
$4.2M21-36%N/AN/A
#8
$10.1M50-25%N/AN/A
#9
$225.5M112219%N/AN/A
#10
$3.2M16-27%N/AN/A
Add Company

What Is Pharmazz?

Pharmazz, Inc. is a clinical stage pharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target critical care medicine. The company is developing several clinical-stage product candidates, PMZ-2010 (Centhaquine), PMZ-1620 (Sovateltide) and PMZ-2123 for which it holds global marketing rights.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$8.8M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pharmazz News

2022-04-17 - Brain Edema Treatment Market Size, Share, Growth 2022 ...

Pharmazz Inc; Remedy Pharmaceuticals Inc. Brain Edema Treatment Market Breakdown by Type: PMZ-2123; FG-4497; Glyburide; Others.

2022-03-22 - Pharmazz Inc. announces FDA clearance of an IND ...

About Pharmazz, Inc. Pharmazz, Inc. is a privately held company engaged in developing novel products in critical care medicine. Additional...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.9M57-5%N/A
#2
$26.2M1404%N/A